Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms × Buprenorphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cancer Pain 2 Neoplasms 1 Chronic Pain 1

Interventions

Dexamethasone 7 Oxycodone 6 Propofol 4 Epoetin Alfa 4 Zoledronic Acid 3 Sevoflurane 3 Palonosetron 3 Ondansetron 3 Naloxone 3 Everolimus 3 Cholecalciferol 3 Calcium Dobesilate 3 Bevacizumab 3 Aspirin 3 Aprepitant 3 peginterferon alfa-2a 2 edoxaban 2 apixaban 2 apatinib 2 Vitamin B 12 2 Vancomycin 2 Tobacco Use Cessation Devices 2 Tablets 2 Surgical Procedures, Operative 2 Sodium Chloride 2 Saline Solution 2 Rivaroxaban 2 Octreotide 2 Morphine 2 Metoclopramide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01809106 2015-12-24

CERP

Mario Negri Institute for Pharmacological Research

Phase 4 Completed

518 enrolled 11 charts

Cancer Pain, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡